Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.245 EUR | +2.98% | +6.40% | -14.31% |
Apr. 15 | Sanofi: progress in hematology trial | CF |
Apr. 15 | Innate Pharma: progress in hematology trial | CF |
Evolution of the average Target Price on Innate Pharma
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Innate Pharma
SVB Leerink |
EPS Revisions
- Stock Market
- Equities
- IPH Stock
- Consensus Innate Pharma